Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Solicitation opportunity from Department Of Defense was posted on April 27, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

GUAIFENESIN EXTENDE

Closed
SPE2DP-26-T-3112Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325411
New
DIBBS
LIDOCAINE HYDROCHLO
Solicitation # SPE2DP-26-T-4997
Solicitation SPE2DP-26-T-4997 is a Request for Quotations issued by the DLA Troop Support Medical Supply Chain for the procurement of Lidocaine Hydrochloride 2% mucosal jelly. The requirement consists of two boxes of sterile topical anesthetic, with each box containing ten 11ml single-use prefilled plastic syringes, each providing 220 mg of the substance. The items are identified by NSN 6505-01-707-4169 and are subject to a non-extendable shelf-life requirement of 36 months. Delivery is required within 20 days after the order, with an original required delivery date of May 1, 2025. The shipping terms are FOB Destination, with primary delivery to Camp Pendleton, California, and a bulk break point in Palmerston, Australia. The contractor must adhere to strict packaging and marking standards, including MIL-STD-2073-1E, RP001 for palletization, and Medical Marking Standard No. 1. All items must be packaged in sealed unit containers to prevent damage and labeled according to the Hazard Communication Standard where applicable. Inspection and acceptance will occur at the destination. Administrative requirements include the use of the Wide Area WorkFlow system for invoicing and compliance with various FAR and DFARS clauses, including the Buy American and Balance of Payments Program and safeguarding of covered defense information. Quotations for this requirement were due by September 16, 2026.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 4 days

AI Contract Overview

Show more

Guaifenesin Extended-Release Tablets, 1200 mg per tablet, are procured in blister packs containing 14 tablets each, with two boxes total constituting the order. This is a maximum-strength formulation designed to relieve chest congestion by thinning and loosening mucus through immediate and extended-release bi-layer technology. The product is intended for adult use only and must not be administered to children under 12 years of age. Storage must be maintained between 20–25°C (68–77°F), and the item has a non-extendable shelf life of 36 months as per RS020 requirements. Packaging must comply with DLA’s procurement standards and Medical Marking Standard No. 1, superseding MIL-STD-129; each unit must be sealed in commercial packaging that ensures protection against damage and safe delivery via common carrier at the lowest freight rate. Palletization and marking must adhere to RP001 and special marking instructions. The material is subject to Covered Defense Information protocols and must be shipped by traceable means, excluding parcel post. The contract, issued under solicitation SPE2DP-26-T-3112 by the Department of Defense’s Medical Supply Chain Pharmaceutical FSA, requires delivery of 2 boxes to Fort Bragg, North Carolina, within 20 days from the required delivery date of April 28, 2026. Quantity is fixed with zero variance allowed. The NSN is 6505-01-724-9533, and the units are supplied by AmerisourceBergen Drug Corp and RB Health US LLC under NDC codes 46122-0683-74 and 63824-0023-35 respectively. Inspection and acceptance occur at the destination. Technical and quality standards referenced under RA001 are governed by the DLA Master List in effect on the solicitation issue date. The point of contact is Alec Deichman, and the shipment must be tracked using the provided TCN, with all government-specific identifiers applied as required for defense logistics compliance.

General Info

1200 mg guaifenesin tablets, 2 boxes, adult use only, 36-month shelf life, shipped to Fort Bragg by April 28, 2026.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325411 - Medicinal and Botanical ManufacturingView NAICS

Place of Performance

5234 EAGLE TALON DR BLDG X3063, FORT BRAGG, NC, 28310, USA

Set-Aside

NONE

Documents

(1)

SPE2DP-26-T-3112.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUSA
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUSA

Full Description

Show more
GUAIFENESIN EXTENDE
GUAIFENESIN EXTENDED-RELEASE TABLETS
UNIT OF ISSUE: 1200MG 14 TABLETS
RELIEVES CHEST CONGESTION; THINS AND LOOSENS MUCUS; IMMEDIATE AND EXTEND
RELEASE BI-LAYER TABLETS, THIN BRONCHIAL SECRETIONS, BOX OF 1 BLISTER
PACK<(>,<)>
CONTAINING 14 TABLETS; DO NOT USE FOR CHILDREN UNDER 12 YEARS OF AGE;
STORE
AT 20-25 C (68-77 F). GUAIFENESIN 1200 MG; MAXIMUM STRENGTH.
RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS (IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
AMERISOURCEBERGEN DRUG CORP 1XUY5 P/N NDC46122-0683-74
RB HEALTH US LLC 860J1 P/N NDC63824-0023-35
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016505411 0001 BX 2.000
NSN/MATERIAL:6505017249533
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
SPE2DP-26-T-3112
SECTION B
PR: 7016505411 PRLI: 0001 CONT’D
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
QUP:001 PRES MTHD:ZZ CLNG/DRY:Z PRESV MAT:ZZ
WRAP MAT:ZZ CUSH/DUNN MAT:ZZ CUSH/DUNN THKNESS:Z
UNIT CONT:ZZ OPI:M
INTRMDTE CONT:ZZ INTRMDTE CONT QTY:ZZZ
PACK CODE:U
MARKING SHALL BE IN ACCORDANCE WITH MIL-STD-129.
SPECIAL MARKING CODE:ZZ -ZZ Special Requirements
PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
BULK BREAK POINT:
W91KBP
0003 SF BN 01 CO A SUSTAINMEN
3D SFG SSA AWCF SSF
5234 EAGLE TALON DR BLDG X3063
FORT BRAGG NC 28310
US
SHIP BY TRACEABLE MEANS. DO NOT USE PARCEL POST.
FREIGHT SHIPPING ADDRESS:
W91KBP
0003 SF BN 01 CO A SUSTAINMEN
3D SFG SSA AWCF SSF
SPE2DP-26-T-3112
SECTION B
PR: 7016505411 PRLI: 0001 CONT’D
5234 EAGLE TALON DR BLDG X3063
FORT BRAGG NC 28310
US
MARKFOR
W91KBP
0003 SF BN 01 CO A SUSTAINMEN
3D SFG SSA AWCF SSF
5234 EAGLE TALON DR BLDG X3063
FORT BRAGG NC 28310
US
M/F: (TCN) W91KBP61060088
RDD: 120
PROJ: TP 3
SUPP ADD: W9046W SIG: C
FOR GOVERNMENT USE ONLY: (IPD) 12
DIC: A0A DIST: V ADV: 2A FC: Z9
Need Ship Date:00/00/0000 Original Required Delivery Date:04/28/2026
SPE2DP-26-T-3112 NSN/Part Number: 6505-01-724-9533 Quantity: 2 BX Purchase Request: 7016505411QTY: 2 Delivery: 20 days ADO

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS